Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial

Background. Modified vaccinia Ankara (MVA-BN, IMVAMUNE) is emerging as a primary immunogen and as a delivery system to treat or prevent a wide range of diseases. Defining the safety and immunogenicity of MVA-BN in key populations is therefore important. Methods. We performed a dose-escalation study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Walsh, Stephen R., Wilck, Marissa B., Dominguez, David J., Zablowsky, Elise, Bajimaya, Shringkhala, Gagne, Lisa S., Verrill, Kelly A., Kleinjan, Jane A., Patel, Alka, Zhang, Ying, Hill, Heather, Acharyya, Aruna, Fisher, David C., Antin, Joseph H., Seaman, Michael S., Dolin, Raphael, Baden, Lindsey R.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654753/
https://ncbi.nlm.nih.gov/pubmed/23482644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jit105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados